Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate in Asymptomatic Stage I Multiple Myeloma
NCT00733538Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Dec 2004
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in multiple myeloma (MM), sponsored by Centre Hospitalier Universitaire de Nice. Started Dec 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00733538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733538.